THUNA LAXATIVE TAB 45.3 MG — DIN 00384488
BALMONY : 45.3 MG SENNA : 113.75 MG GLYCYRRHIZA GLABRA : 45.3 MG JUGLANS CINEREA : 68.25 MG CASCARA SAGRADA : 259.35 MG FENNEL : 22.75 MG BLACKROOT : 68.25 MG · THUNA HERBAL REMEDIES LTD. · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is THUNA LAXATIVE TAB?
THUNA LAXATIVE TAB 45.3 MG contains BALMONY : 45.3 MG SENNA : 113.75 MG GLYCYRRHIZA GLABRA : 45.3 MG JUGLANS CINEREA : 68.25 MG CASCARA SAGRADA : 259.35 MG FENNEL : 22.75 MG BLACKROOT : 68.25 MG. It is listed in the Health Canada Drug Product Database under DIN 00384488, held by THUNA HERBAL REMEDIES LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 16-Oct-2002. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Contact Laxatives In Combination in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
46 holders have a Canadian DIN containing Contact Laxatives In Combination, across 60 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SABEX INC | 4 | 0 | BICHOLATE LILAS, BICHOLATE LILAS TAB, MUCINUM (CASCARA AND SENNA TABLETS), MUCINUM TAB | No marketed DIN |
| LABORATOIRE LALCO INC. | 3 | 0 | CONSTIPATION, LAXATIVE, LAXATIVE TAB | No marketed DIN |
| NATURE'S WAY OF CANADA LTD. | 3 | 0 | MULTILAX 2 CAP, MULTILAX 2 TAB, MULTILAX 3 CAP | No marketed DIN |
| BIO VITA | 2 | 0 | DERATIN LIQ, VITA-LAX | No marketed DIN |
| FREGA INC. | 2 | 0 | VESILAX, VESILAX+ | No marketed DIN |
| HERBES UNIVERSELLES INC. | 2 | 0 | HERBA TONE, TRIOLAX TAB | No marketed DIN |
| NOBEL PHARM ENR. | 2 | 0 | AID-LAX TAB, INFUSION NATURELLE LAXATYL - PCK (SACHET) | No marketed DIN |
| ROLMEX INTERNATIONAL INC. | 2 | 0 | CHOLASYN, CHOLASYN II | No marketed DIN |
| SANTÉ NATURELLE (AG) LTÉE | 2 | 0 | HERBALAX, HERBALAX FORTE NO 70 TAB | No marketed DIN |
| THUNA HERBAL REMEDIES LTD. | 2 | 0 | THUNA LAXATIVE TAB, THUNAS WORM BALSAM | No marketed DIN |
| CARMARAN LTÉE | 1 | 0 | LAXATEX TAB | No marketed DIN |
| CARTER PRODUCTS, DIVISION OF CARTER WALLACE NS INC. | 1 | 0 | CARTERS LITTLE PILLS TAB | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 45.3 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Contact Laxatives In Combination |
|---|---|
| ATC code | A06AB20 |
| AHFS class | 56:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00384488 |
|---|---|
| DIN (unpadded, as printed on some documents) | 384488 |
| Brand name | THUNA LAXATIVE TAB |
| Generic / active ingredient | BALMONY : 45.3 MG SENNA : 113.75 MG GLYCYRRHIZA GLABRA : 45.3 MG JUGLANS CINEREA : 68.25 MG CASCARA SAGRADA : 259.35 MG FENNEL : 22.75 MG BLACKROOT : 68.25 MG |
| Market authorization holder | THUNA HERBAL REMEDIES LTD. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AB20 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A06AB |
| Current status | CANCELLED POST MARKET |
| Status date | 16-Oct-2002 |
| Original market date | 1961-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 60 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AID-LAX TAB | 12 MG | TABLET | NOBEL PHARM ENR. | CANCELLED POST MARKET | 00750212 |
| ALSILINE | 60 MG | TABLET | ALSI CIE LTEE | CANCELLED POST MARKET | 00445258 |
| BEKUNIS DRAGEES | 5 MG | TABLET | ROHA ARZNEIMITTEL GMBH | CANCELLED POST MARKET | 00402435 |
| BICHOLATE LILAS | 5 MG | TABLET | SABEX INC | CANCELLED POST MARKET | 02236732 |
| BICHOLATE LILAS TAB | 100 MG | TABLET | SABEX INC | CANCELLED POST MARKET | 00888648 |
| BILEX TAB | 100 MG | TABLET | BIODO ENRG | CANCELLED POST MARKET | 00426237 |
| C OTTWAYS LAX TAB | 28 MG | TABLET | C OTTWAY HERBALIST | CANCELLED POST MARKET | 00329398 |
| CARTERS LITTLE PILLS TAB | 16 MG | TABLET | CARTER PRODUCTS, DIVISION OF CARTER WALLACE NS INC. | CANCELLED POST MARKET | 00411817 |
| CHOLASYN | 50 MG | TABLET | ROLMEX INTERNATIONAL INC. | CANCELLED POST MARKET | 02236803 |
| CHOLASYN II | 25 MG | TABLET | ROLMEX INTERNATIONAL INC. | CANCELLED POST MARKET | 00499447 |
2 · Same class — other molecules in ATC A06AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Bisacodyl | AG-BISACODYL EC · ALOPHEN TABLETS · AMB-BISACODYL · APO-BISACODYL · +46 more | 59 | 16 | Yes |
| Senna Glycosides, Combinations | CENNLACS · COLACE PLUS STIMULANT LAXATIVE · DOCUSEN · EX-LAX GENTLE STRENGTH · +14 more | 18 | 5 | Yes |
| Sodium Picosulfate, Combinations | CITRACLEEN · ORAL PURGATIVE · PICO-SALAX · PICODAN · +2 more | 6 | 2 | Yes |
| Bisacodyl, Combinations | BI-PEGLYTE · FRUITATIVES ECT · GENTLAX S · JAMPLYTE + BISACODYL | 4 | 2 | Yes |
| Contact Laxatives In Combination | AID-LAX TAB · ALSILINE · BEKUNIS DRAGEES · BICHOLATE LILAS · +54 more | 60 | 0 | Not in Canada |
| Cascara | AROMATIC CASCARA SAGRADA COMPOUND · BIOFANT - 41MG/5ML · CASCARA AROMATIC · CASCARA AROMATIC LIQ 250MG · +15 more | 21 | 0 | Not in Canada |
| Cascara, Combinations | ACIDOBYL & CASCARA · ALSILAX · BYLIUM LIQ · CHOLETOL · +15 more | 19 | 0 | Not in Canada |
| Senna Glycosides | AGAROL EXTRA STRENGTH CHEWABLE LAXATIVE TABLETS · AGAROL WITH SENNOSIDES · CASTORIA LIQ 0.7MG/ML · FLORA HERBTEA SENNA LEAVES · +14 more | 19 | 0 | Not in Canada |
| Castor Oil | CASTOR OIL · CASTOR OIL CERTIFIED · CASTOR OIL LIQ · CASTOR OIL LIQ 100% · +6 more | 12 | 0 | Not in Canada |
| Phenolphthalein, Combinations | CALCIUM DOCUPHEN CAP · CORRECTOL LAXATIVE TAB · DOXIDAN CAPSULES · EX-LAX LIGHT FORMULA LAX W STOOL SOFTEN TAB · +2 more | 9 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A06AA | Docusate Sodium · Docusate Sodium, Combinations · Liquid Paraffin · Liquid Paraffin, Combinations | 144 | 22 |
| A06AD | Lactulose · Macrogol · Macrogol, Combinations · Magnesium Oxide · Magnesium Sulphate · +5 more | 86 | 21 |
| A06AX | Glycerol · Linaclotide · Lubiprostone · Other Laxatives · Plecanatide · +2 more | 30 | 14 |
| A06AH | Methylnaltrexone Bromide · Naloxegol | 5 | 3 |
| A06AG | Bisacodyl · Combinations · Docusate Sodium, Incl Combinations · Sodium Phosphate | 7 | 1 |
| A06AC | Ispaghula (Psylla Seeds) · Ispaghula, Combinations · Linseed · Methylcellulose · Polycarbophil Calcium · +2 more | 79 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.